TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.74 -0.08 (-10.64%) 0.0 (-0.08%) 0.02 (3.35%) -0.02 (-2.3%) -0.08 (-10.64%) 0.42 (94.36%) -0.14 (-16.57%) -0.18 (-21.57%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.3417
Diluted P/E:
-0.3417
RSI(14) 1m:
58.65
VWAP:
0.65
RVol:
0.0961

Events

Period Kind Movement Occurred At

Related News